GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » AptarGroup Inc (FRA:AGT) » Definitions » Total Liabilities

AptarGroup (FRA:AGT) Total Liabilities : €1,908 Mil (As of Mar. 2024)


View and export this data going back to 2008. Start your Free Trial

What is AptarGroup Total Liabilities?

AptarGroup's Total Liabilities for the quarter that ended in Mar. 2024 was €1,908 Mil.

AptarGroup's quarterly Total Liabilities increased from Sep. 2023 (€1,953.21 Mil) to Dec. 2023 (€1,953.75 Mil) but then declined from Dec. 2023 (€1,953.75 Mil) to Mar. 2024 (€1,908.22 Mil).

AptarGroup's annual Total Liabilities increased from Dec. 2021 (€1,908.74 Mil) to Dec. 2022 (€2,015.68 Mil) but then declined from Dec. 2022 (€2,015.68 Mil) to Dec. 2023 (€1,953.75 Mil).


AptarGroup Total Liabilities Historical Data

The historical data trend for AptarGroup's Total Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

AptarGroup Total Liabilities Chart

AptarGroup Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Total Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1,790.88 1,758.48 1,908.74 2,015.68 1,953.75

AptarGroup Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Total Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,031.49 1,993.02 1,953.21 1,953.75 1,908.22

AptarGroup Total Liabilities Calculation

Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.

AptarGroup's Total Liabilities for the fiscal year that ended in Dec. 2023 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1147.45+(666.159+65.123
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+17.438+57.583)
=1,954

Total Liabilities=Total Assets (A: Dec. 2023 )-Total Equity (A: Dec. 2023 )
=4082.383-2128.63
=1,954

AptarGroup's Total Liabilities for the quarter that ended in Mar. 2024 is calculated as

Total Liabilities=Total Current Liabilities+Total Noncurrent Liabilities
=Total Current Liabilities+(Long-Term Debt & Capital Lease Obligation+Other Long-Term Liabilities
=1100.447+(666.04+67.064
+NonCurrent Deferred Liabilities+PensionAndRetirementBenefit)
+15.646+59.024)
=1,908

Total Liabilities=Total Assets (Q: Mar. 2024 )-Total Equity (Q: Mar. 2024 )
=4082.119-2173.898
=1,908

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


AptarGroup Total Liabilities Related Terms

Thank you for viewing the detailed overview of AptarGroup's Total Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


AptarGroup (FRA:AGT) Business Description

Traded in Other Exchanges
Address
265 Exchange Drive, Suite 301, Crystal Lake, IL, USA, 60014
Headquartered in Crystal Lake, Illinois, AptarGroup is a leading global supplier of dispensing systems such as aerosol valves, pumps, and closures to the consumer goods and pharmaceutical markets. With the bulk of its annual net sales coming from Europe (50% of sales) and the United States (33%), Aptar aims to increase its presence in Asia (10%) and Latin America (7%). Aptar's pharmaceutical division generates roughly one third of group sales but over two thirds of group profits.

AptarGroup (FRA:AGT) Headlines